Medical Condition News

RSS

Study presents oxytocin as latest treatment target for age-related muscle wasting

Researchers at the University of California, Berkeley, have discovered that oxytocin -- a hormone associated with maternal nurturing, social attachments, childbirth and sex -- is indispensable for healthy muscle maintenance and repair, and that in mice, it declines with age.

11 Jun 2014

Researchers discover new class of tumor

This is the story of two perfectly harmless genes. By themselves, PAX3 and MAML3 don't cause any problems. However, when they combine during an abnormal but recurring chromosomal mismatch, they can be dangerous.

11 Jun 2014

Autism Speaks collaborates with Google to develop world's largest genomic database on autism

Autism Speaks, the world's leading autism science and advocacy organization, today announced a collaboration with Google to develop the world's largest database of genomic sequence information on individuals with autism spectrum disorder (ASD) and their family members.

11 Jun 2014

Bayer HealthCare seeks EU marketing authorization of EYLEA for macular edema following BRVO

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO).

11 Jun 2014

Type 2 diabetes Patients who take metformin plus insulin at higher risk for heart disease, death

Patients with type 2 diabetes who take a combination of metformin plus insulin may be at higher risk for cardiovascular disease and death compared with those who take a combination of metformin plus sulfonylurea, according to a new study funded by the Agency for Healthcare Research and Quality that appears in the June 11 issue of JAMA.

11 Jun 2014

EU-funded project aims to identify potential new targets for cancer therapy

Targeted therapies have revolutionised the treatment of cancer since they were first introduced. Amongst the first medications approved in Europe, was the breast cancer drug Herceptin, which was approved in 2000. Then, the drug Glivec, was initially introduced to treat a certain form of leukaemia, and approved in 2001. Targeted therapies specifically inhibit molecules within so-called signalling pathways that usually control cell growth, death and differentiation. If they are altered, for example falsely inactivated or activated, the cells may start growing in an uncontrolled manner.

11 Jun 2014

Instant oatmeal provides greater satiety than equal calories of ready-to-eat oat cereal

New research published in the Nutrition Journal reveals that calorie-for-calorie, even a serving of instant oatmeal is more filling than a ready-to-eat (RTE), oat-based cereal.

11 Jun 2014

New framework for monitoring oral cancer development, progression, recurrence

Each year, approximately 22,000 Americans are diagnosed with oral cancer. The five-year survival rate of 40% in the U.S. is one of the lowest of the major cancers, and it has not improved in the past 40 years.

11 Jun 2014

Adding evidence-based weight loss strategies enhances statewide wellness campaign

Researchers from The Miriam Hospital have found that adding evidence-based weight loss strategies to a statewide wellness campaign improves weight loss outcomes among participants. The study and its findings are published online in advance of print in the American Journal of Public Health.

11 Jun 2014

Study reports that regular blood donors have fewer heart attacks, strokes

Many know that donating blood saves lives, but the life you save just may be your own.

11 Jun 2014

Researchers discover strong genetic risk factor for type 2 diabetes in Latin American patients

In the largest study of its kind published to date, an international team of researchers in Mexico and the United States has discovered a strong genetic risk factor for type 2 diabetes that primarily affects Latin American patients, but is rare elsewhere.

11 Jun 2014

Children of parents with BD are at greater risk of developing psychiatric disorders

Bipolar disorder (BD) is among the 10 most burdensome medical conditions, according to the World Health Organization. The disorder is known for its dramatic highs of extreme euphoria, racing thoughts and decreased need for sleep, as well as its profound lows of sadness and despair.

11 Jun 2014

Mirna enrolls first patient in hematological malignancy cohort of MRX34 Phase 1 clinical trial

Mirna Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering microRNA-based Replacement Therapy to treat cancer, today announced the enrollment of the first patient in the hematological malignancy cohort of its ongoing Phase 1 clinical trial of MRX34, the company's lead product candidate and first microRNA mimic in human clinical trials in oncology.

11 Jun 2014

Northwest Biotherapeutics initiates Phase III trial of DCVax-L in Germany

Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced today that it has initiated the Phase III trial of DCVax-L in Germany.

10 Jun 2014

Alkermes initiates FORWARD-3 and FORWARD-4 efficacy studies in pivotal clinical program for ALKS 5461

Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).

10 Jun 2014

New therapeutic interventions could render addiction into manageable disease

Neuroscientists agree that abuse of drugs hijacks circuits in the brain that are crucial for decision-making, but society as a whole tends to stigmatize addicted people for lacking self-control.

10 Jun 2014

electroCore's non-invasive vagus nerve stimulation therapy reduces cluster headache attacks

In a multi-center, randomized, trial across Europe, electroCore's non-invasive vagus nerve stimulation (nVNS) therapy was found to meet its primary endpoint of statistical significance in reducing the number of cluster headache attacks when compared with the standard of care.

10 Jun 2014

Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity and clinical responses of its immunotherapy product, INO-3112, in treating human papillomavirus (HPV)- associated head and neck cancer.

10 Jun 2014

Aetna partners with Fresenius Medical Care to improve lives of people with end stage renal disease

Fresenius Medical Care announced today a collaborative care model designed to improve the quality of care for Aetna's Medicare Advantage members who have end stage renal disease, while lowering health care costs.

10 Jun 2014

School prevention program can dramatically cut teen cigarette smoking in Italy

Results from a new multi-year initiative provide further evidence that a school prevention program called Botvin LifeSkills Training (LST) can dramatically cut teen cigarette smoking. After identifying LST as the top-rated prevention program, researchers in Italy translated the LST program into Italian and adapted it for Italian youth.

10 Jun 2014

Medical Condition News

Study presents oxytocin as latest treatment target for age-related muscle wasting

Researchers discover new class of tumor

Autism Speaks collaborates with Google to develop world's largest genomic database on autism

Bayer HealthCare seeks EU marketing authorization of EYLEA for macular edema following BRVO

Type 2 diabetes Patients who take metformin plus insulin at higher risk for heart disease, death

EU-funded project aims to identify potential new targets for cancer therapy

Instant oatmeal provides greater satiety than equal calories of ready-to-eat oat cereal

New framework for monitoring oral cancer development, progression, recurrence

Adding evidence-based weight loss strategies enhances statewide wellness campaign

Study reports that regular blood donors have fewer heart attacks, strokes

Researchers discover strong genetic risk factor for type 2 diabetes in Latin American patients

Children of parents with BD are at greater risk of developing psychiatric disorders

Mirna enrolls first patient in hematological malignancy cohort of MRX34 Phase 1 clinical trial

Northwest Biotherapeutics initiates Phase III trial of DCVax-L in Germany

Alkermes initiates FORWARD-3 and FORWARD-4 efficacy studies in pivotal clinical program for ALKS 5461

New therapeutic interventions could render addiction into manageable disease

electroCore's non-invasive vagus nerve stimulation therapy reduces cluster headache attacks

Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Aetna partners with Fresenius Medical Care to improve lives of people with end stage renal disease

School prevention program can dramatically cut teen cigarette smoking in Italy

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News